Elena Rybakina to Withdraw from US Open 2026? – Decoding from an Injury and Data Perspective

Cincinnati, Ohio – When Elena Rybakina stepped onto the center court at the Cincinnati Open to face Iga Swiatek, no one in the stands expected the match to end after just five games. The 1-4 scoreline in the first set did not reflect a tactical battle – it reflected a body refusing to obey. The Kazakh player left the court in silence, and the biggest question of the hard-court summer began to take shape: Can she compete at the US Open 2026? The context goes beyond an ordinary injury case. Rybakina is in the race for the World No. 1 ranking, with a mandatory target of reaching the semi-finals in New York to secure the top spot. A mandatory goal, not an optional one – and that creates a different kind of pressure compared to her previous Grand Slam campaigns. When an athlete is forced to compete for rankings rather than for physical readiness, the line between courage and recklessness becomes dangerously thin. According to ESPN, the issue lies in the tendon of Rybakina's left heel. This area bears enormous load in modern tennis – it is where explosive force, sudden stops, and direction changes originate. Meanwhile, other sources mention the possibility of an Achilles injury, but this information remains speculative. The difference in reliability matters: an ESPN diagnosis carries different weight than an unverified rumor. What concerns me most in this situation is not Rybakina's serve or forehand – it is her movement. She herself admitted she "could not move her leg" when trying to continue at Cincinnati. For an aggressive baseliner whose game relies on power and explosiveness, losing movement means losing half of her most important weapons. Even the most powerful serve cannot hide legs that cannot position the body correctly. Data from the Cincinnati match is almost meaningless tactically – only five games, not enough to assess serve rhythm, return position, or baseline footwork. But this very data void is itself an important signal. When a player cannot complete a set against a top opponent, we have no evidence that her skills remain intact. I have followed enough seasons to know that data gaps like this often precede bigger problems. Another notable detail: the decision to continue for one more service game before retiring. This can be interpreted two ways. One is competitive courage – the will to fight to the end. The other is poor risk assessment – a player who cannot move her leg should not continue. There is no information indicating medical staff cleared her to continue, and in such cases, the silence of the medical team is itself worth questioning. What worries me even more is the history of heel tendon injuries in modern tennis. These injuries are typically load-related – not a single incident but the result of months, even years of repeated stress. The strapping visible before the Cincinnati match could indicate the problem existed earlier – but this is speculation, not conclusion. I do not believe in luck; I believe in verified numbers. Now, let me address the counterintuitive perspective. Many will say Rybakina should try to compete at the US Open because the opportunity to reach World No. 1 is too great. But I argue the opposite: this ranking objective is her greatest danger. When an athlete enters a Grand Slam with a mandatory semi-final target, she will tend to push her body beyond safe limits. Seven matches at a Grand Slam is an enormous workload – if the heel tendon has not fully healed, the risk of a more serious injury is very high. I have witnessed too many cases of athletes rushing back due to ranking pressure, and the result is often a more severe injury lasting months. Data never lies; only our interpretation of it can be wrong. And in this case, the data is saying that a body that cannot move cannot compete at Grand Slam level. Withdrawing from the mixed doubles at the US Open is a reasonable decision – but it is also a signal. When a player starts cutting events to focus on the main draw, it shows they are managing load very carefully. The question is: is withdrawing from mixed doubles enough to protect the body for singles? I doubt it. Look at the history of heel tendon injuries in tennis. This is not an injury that resolves in a week. Recovery typically takes weeks, even months, depending on severity. If Rybakina's issue is indeed in the Achilles tendon, competing at the US Open just weeks after retiring at Cincinnati is an enormous risk. I find the gap not in the player's body but in how we measure it. We measure rankings, win counts, titles – but we rarely measure true physical readiness. An athlete can be World No. 1 but unable to compete – that is an irony the sports industry has yet to solve. From a long-term perspective, I believe the wisest decision for Rybakina right now is to withdraw from the US Open 2026, accept losing the chance at World No. 1, and focus entirely on recovery. She is only 27 – there are many seasons ahead. But if she tries to compete in New York with an unhealed injury, she may pay with months, even years of her career. Injury is a story – but that story begins long before the player falls. For Rybakina, this story may have begun weeks before Cincinnati. The biggest question is not whether she will compete at the US Open – it is whether she is wise enough to listen to her body before it is too late. Meanwhile, I will continue to follow the data. I will watch for any information from her medical team about MRI results or specific treatment plans. Without that data, all predictions are guesses. But one thing I know for certain: a risk model saves no one; it only tells you where to look. And right now, all indicators are pointing in one direction: Elena Rybakina's body needs rest, not competition.